☆ 4.5 Meeting Abstract

Capsid-engineered adeno-associated virus (AAV) vector for neurotrophin gene therapy in inner ear disease

HUMAN GENE THERAPY (2022)

Rate this paper

The primary rating indicates the level of overall quality for the paper. Secondary ratings independently reflect strengths or weaknesses of the paper.

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Capsid-engineered adeno-associated virus (AAV) vector for neurotrophin gene therapy in inner ear disease

Rate this paper

Find Funding. Review Successful Grants.

Discover Peeref hubs

Export Citation

Share Paper